These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10072682)

  • 21. Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.
    Zlotos DP; Gündisch D; Ferraro S; Tilotta MC; Stiefl N; Baumann K
    Bioorg Med Chem; 2004 Dec; 12(23):6277-85. PubMed ID: 15519170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
    Prilla S; Schrobang J; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide.
    Huang XP; Prilla S; Mohr K; Ellis J
    Mol Pharmacol; 2005 Sep; 68(3):769-78. PubMed ID: 15937215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of ligand binding to muscarinic M(2) acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators.
    Raasch A; Scharfenstein O; Tränkle C; Holzgrabe U; Mohr K
    J Med Chem; 2002 Aug; 45(17):3809-12. PubMed ID: 12166953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric binding sites on muscarinic acetylcholine receptors.
    Wess J
    Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptors.
    Staudt M; Tränkle C; Mohr K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Aug; 336(8):385-9. PubMed ID: 14502759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative interactions at M2 muscarinic acetylcholine receptors: structure/activity relationships in stepwise shortened bispyridinium- and bis(ammonio)alkane-type allosteric modulators.
    Gilsbach R; Grossmüller M; Alptüzün V; Erciyas E; Tränkle C; Holzgrabe U; Mohr K
    Neurochem Res; 2003 Apr; 28(3-4):667-73. PubMed ID: 12675159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
    Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
    J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
    Avlani V; May LT; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexamethonium-type allosteric modulators of the muscarinic receptors bearing lateral dibenzazepine moieties.
    Li R; Tränkle C; Mohr K; Holzgrabe U
    Arch Pharm (Weinheim); 2001 Apr; 334(4):121-4. PubMed ID: 11382147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.
    Botero Cid MH; Holzgrabe U; Kostenis E; Mohr K; Tränkle C
    J Med Chem; 1994 May; 37(10):1439-45. PubMed ID: 8182702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligands for the common allosteric site of acetylcholine M2-receptors: development and application.
    Holzgrabe U; Bender W; Cid HM; Staudt M; Pick R; Pfletschinger C; Balatková E; Tränkle C; Mohr K
    Pharm Acta Helv; 2000 Mar; 74(2-3):149-55. PubMed ID: 10812952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.
    Buller S; Zlotos DP; Mohr K; Ellis J
    Mol Pharmacol; 2002 Jan; 61(1):160-8. PubMed ID: 11752217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
    Redka DS; Pisterzi LF; Wells JW
    Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation of the oxime function of bispyridinium-type allosteric modulators of M2-cholinoceptors.
    Gasteiger J; Holzgrabe U; Kostenis E; Mohr K; Sürig U; Wagener M
    Pharmazie; 1995 Feb; 50(2):99-105. PubMed ID: 7700977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors.
    Zlotos DP; Buller S; Tränkle C; Mohr K
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2529-32. PubMed ID: 11086722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
    May LT; Lin Y; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of lateral substituents in heptane-bisammonium derivatives to the allosteric stabilization of antagonist binding to M2-receptors.
    Staudt M; Tränkle C; Mohr K; Holzgrabe U
    Life Sci; 1998; 62(5):423-9. PubMed ID: 9449232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
    Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
    J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.